Entering a new era of antiplatelet therapy: the 4D-ACS trial.
作者信息
Laudani Claudio, Gragnano Felice, Galli Mattia
机构信息
Division of Cardiology, Azienda Ospedaliero-Universitaria Policlinico 'Rodolico-San Marco', University of Catania, Catania 95100, Italy.
Division of Cardiology, University of Florida College of Medicine, Jacksonville, FL 32209, USA.
出版信息
Eur Heart J Cardiovasc Pharmacother. 2025 Aug 12;11(5):402. doi: 10.1093/ehjcvp/pvaf045.
Abstract
摘要
相似文献
1
Entering a new era of antiplatelet therapy: the 4D-ACS trial.步入抗血小板治疗新时代：4D-ACS试验
Eur Heart J Cardiovasc Pharmacother. 2025 Aug 12;11(5):402. doi: 10.1093/ehjcvp/pvaf045.
2
One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial.为期1个月的双联抗血小板治疗，随后以较低剂量的普拉格雷单药治疗：4D-ACS随机试验
EuroIntervention. 2025 Jul 21;21(14):e796-e809. doi: 10.4244/EIJ-D-25-00331.
3
Indobufen versus aspirin after percutaneous coronary intervention in elderly patients with acute coronary syndrome.吲哚布芬与阿司匹林用于老年急性冠状动脉综合征患者经皮冠状动脉介入治疗后的比较
BMC Cardiovasc Disord. 2025 Jul 7;25(1):495. doi: 10.1186/s12872-025-04843-0.
4
Use of new-generation oral anticoagulant agents in patients receiving antiplatelet therapy after an acute coronary syndrome: systematic review and meta-analysis of randomized controlled trials.急性冠状动脉综合征后接受抗血小板治疗患者中新一代口服抗凝剂的应用：随机对照试验的系统评价和荟萃分析
Arch Intern Med. 2012 Nov 12;172(20):1537-45. doi: 10.1001/archinternmed.2012.4026.
5
Differential effects of dual antiplatelet therapy in patients presented with acute coronary syndrome vs. stable ischaemic heart disease after coronary artery bypass grafting.冠状动脉旁路移植术后急性冠状动脉综合征与稳定型缺血性心脏病患者双联抗血小板治疗的差异效应。
Eur Heart J Cardiovasc Pharmacother. 2021 Nov 3;7(6):517-526. doi: 10.1093/ehjcvp/pvaa080.
6
Aspirin-Free Strategy for PCI in Patients With High Bleeding Risk With or Without Acute Coronary Syndrome: A Subgroup Analysis From the STOPDAPT-3 Trial.高出血风险伴或不伴急性冠状动脉综合征患者PCI的无阿司匹林策略：来自STOPDAPT-3试验的亚组分析
Circ Cardiovasc Interv. 2025 May 14:e015197. doi: 10.1161/CIRCINTERVENTIONS.124.015197.
7
Prasugrel (Efient®) with percutaneous coronary intervention for treating acute coronary syndromes (review of TA182): systematic review and economic analysis.普拉格雷（Efient®）联合经皮冠状动脉介入治疗急性冠状动脉综合征（TA182综述）：系统评价与经济学分析
Health Technol Assess. 2015 Apr;19(29):1-130. doi: 10.3310/hta19290.
8
Immature platelet fraction and immature platelet count as novel biomarkers of elevated platelet reactivity in NSTE-ACS patients receiving dual antiplatelet therapy.血小板不成熟分数和血小板不成熟计数可作为 NSTE-ACS 患者接受双联抗血小板治疗时血小板高反应性的新型生物标志物。
Adv Clin Exp Med. 2023 Dec;32(12):1465-1470. doi: 10.17219/acem/177406.
9
Clopidogrel Versus Aspirin as Monotherapy Following Dual Antiplatelet Therapy in Patients With Acute Coronary Syndrome Receiving a Drug-Eluting Stent: A Systematic Literature Review and Meta-Analysis.氯吡格雷与阿司匹林单药治疗在接受药物洗脱支架置入的急性冠状动脉综合征患者中的疗效比较：系统文献回顾和荟萃分析。
Clin Cardiol. 2024 Sep;47(9):e24326. doi: 10.1002/clc.24326.
10
Evaluating the efficacy of antiplatelet therapy in spontaneous coronary artery dissection: a scoping review.评估抗血小板治疗在自发性冠状动脉夹层中的疗效：一项范围综述。
Cardiovasc Diagn Ther. 2025 Jun 30;15(3):705-713. doi: 10.21037/cdt-24-108. Epub 2025 Jun 26.
本文引用的文献
1
One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial.为期1个月的双联抗血小板治疗，随后以较低剂量的普拉格雷单药治疗：4D-ACS随机试验
EuroIntervention. 2025 Jul 21;21(14):e796-e809. doi: 10.4244/EIJ-D-25-00331.
2
Sex-related variations in platelet reactivity in presence or absence of antiplatelet therapy.接受或未接受抗血小板治疗时血小板反应性的性别差异。
Eur Heart J Cardiovasc Pharmacother. 2025 Sep 22;11(6):509-517. doi: 10.1093/ehjcvp/pvaf034.
3
P2Y12 inhibitor monotherapy after short DAPT in acute coronary syndrome: a systematic review and meta-analysis.急性冠状动脉综合征中短期 DAPT 后 P2Y12 抑制剂单药治疗：系统评价和荟萃分析。
Eur Heart J Cardiovasc Pharmacother. 2024 Nov 6;10(7):588-598. doi: 10.1093/ehjcvp/pvae057.
4
Impact of ethnicity on antiplatelet treatment regimens for bleeding reduction in acute coronary syndromes: a systematic review and pre-specified subgroup meta-analysis.族群对减少急性冠脉综合征出血的抗血小板治疗方案的影响：系统评价和预先指定的亚组荟萃分析。
Eur Heart J Cardiovasc Pharmacother. 2024 Feb 23;10(2):158-169. doi: 10.1093/ehjcvp/pvad085.
5
Antithrombotic treatment strategies in patients with established coronary atherosclerotic disease.稳定性冠心病患者的抗血栓治疗策略。
Eur Heart J Cardiovasc Pharmacother. 2023 Jul 29;9(5):462-496. doi: 10.1093/ehjcvp/pvad032.
Zotero 插件